豚ワクチン市場：製品、タイプ、対象疾患別-2023-2030年の世界予測

豚ワクチンの世界市場は、2023年に14億7,748万米ドル、CAGR7.47％で大きく成長し、2030年には24億5,813万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の豚ワクチン市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.豚ワクチンの世界市場規模および予測は？

2.予測期間中、世界の豚ワクチン市場を形成するCOVID-19の阻害要因と影響は？

3.豚ワクチンの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.豚ワクチンの世界市場における競争戦略は？

5.豚ワクチンの世界市場における技術動向と規制の枠組みは？

6.豚ワクチンの世界市場における主要ベンダーの市場シェアは？

7.豚ワクチンの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 豚肉の消費量の増加
    • 家畜の健康に関する意識の高まり
  • 抑制要因
    • ワクチンの入手可能性には限りがある
  • 機会
    • 新規ワクチン開発に向けた研究開発
  • 課題
    • 獣医師不足
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 豚ワクチン市場：製品別

• 弱毒生ワクチン
• DNAワクチン
• 不活化ワクチン
• 組換えワクチン
• サブユニットワクチン

第7章 豚ワクチン市場：タイプ別

• アクチノバチルス・プルウロニューモニエ
• 古典的豚コレラ
• 口蹄疫
• ヒョウさん
• PEDV
• ブタサーコウイルス 2型
• ブタパルボウイルス
• PRRS
• 仮性狂犬病
• 豚インフルエンザ

第8章 豚ワクチン市場対象疾患別

• 関節炎
• ボルデテラ性鼻炎
• 下痢
• 口蹄疫
• 豚サーコウイルス関連疾患
• 豚の生殖器および呼吸器症候群
• 仮性狂犬病
• 豚インフルエンザ

第9章 南北アメリカの豚ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の豚ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの豚ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. SWINE VACCINES MARKET SIZE, 2022 VS 2030
• FIGURE 3. SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SWINE VACCINES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. SWINE VACCINES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2022 VS 2030 (%)
• FIGURE 7. SWINE VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. SWINE VACCINES MARKET DYNAMICS
• FIGURE 9. SWINE VACCINES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. SWINE VACCINES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. SWINE VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. SWINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 11. SWINE VACCINES MARKET SIZE, BY ACTINOBACILLUS PLEUROPNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. SWINE VACCINES MARKET SIZE, BY M. HYO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. SWINE VACCINES MARKET SIZE, BY PEDV, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS TYPE 2, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. SWINE VACCINES MARKET SIZE, BY PORCINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. SWINE VACCINES MARKET SIZE, BY PRRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 22. SWINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. SWINE VACCINES MARKET SIZE, BY BORDETELLA RHINITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. SWINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE , BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME , BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 72. PHILIPPINES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 75. SINGAPORE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. SINGAPORE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 78. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. TAIWAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. TAIWAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. TAIWAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 84. THAILAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. THAILAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. THAILAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 87. VIETNAM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. VIETNAM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. VIETNAM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 94. DENMARK SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. DENMARK SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. DENMARK SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 97. EGYPT SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. EGYPT SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. EGYPT SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 100. FINLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. FINLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. FINLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. FRANCE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. FRANCE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. FRANCE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 106. GERMANY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. GERMANY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. GERMANY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 109. ISRAEL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. ISRAEL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. ISRAEL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 112. ITALY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. ITALY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. ITALY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 115. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 118. NIGERIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. NIGERIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. NIGERIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 121. NORWAY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. NORWAY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. NORWAY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 124. POLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. POLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. POLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 127. QATAR SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. QATAR SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. QATAR SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 130. RUSSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. RUSSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. RUSSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 133. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 139. SPAIN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. SPAIN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SPAIN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 142. SWEDEN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. SWEDEN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. SWEDEN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 145. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 148. TURKEY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. TURKEY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TURKEY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 151. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 154. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 157. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 158. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 159. SWINE VACCINES MARKET LICENSE & PRICING

The Global Swine Vaccines Market is forecasted to grow significantly, with a projected USD 1,477.48 million in 2023 at a CAGR of 7.47% and expected to reach a staggering USD 2,458.13 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Swine Vaccines Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Swine Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines. The Inactivated Vaccines is projected to witness significant market share during forecast period.

Based on Type, market is studied across Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, M. Hyo, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, and Swine Influenza. The Foot & Mouth Disease is projected to witness significant market share during forecast period.

Based on Target Disease, market is studied across Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, and Swine Influenza. The Arthritis is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Swine Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Swine Vaccines Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Swine Vaccines Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Swine Vaccines Market?

4. What is the competitive strategic window for opportunities in the Global Swine Vaccines Market?

5. What are the technology trends and regulatory frameworks in the Global Swine Vaccines Market?

6. What is the market share of the leading vendors in the Global Swine Vaccines Market?

7. What modes and strategic moves are considered suitable for entering the Global Swine Vaccines Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Swine Vaccines Market, by Product, 2022 vs 2030
• 4.3. Swine Vaccines Market, by Type, 2022 vs 2030
• 4.4. Swine Vaccines Market, by Target Disease, 2022 vs 2030
• 4.5. Swine Vaccines Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising consumption of pork meat
    • 5.1.1.2. Growing awareness related to livestock health
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of vaccine
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D for novel vaccine developments
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of veterinary practitioners
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Swine Vaccines Market, by Product

• 6.1. Introduction
• 6.2. Attenuated Live Vaccines
• 6.3. DNA Vaccines
• 6.4. Inactivated Vaccines
• 6.5. Recombinant Vaccines
• 6.6. Subunit Vaccines

7. Swine Vaccines Market, by Type

• 7.1. Introduction
• 7.2. Actinobacillus Pleuropneumoniae
• 7.3. Classical Swine Fever
• 7.4. Foot & Mouth Disease
• 7.5. M. Hyo
• 7.6. PEDV
• 7.7. Porcine Circovirus Type 2
• 7.8. Porcine Parvovirus
• 7.9. PRRS
• 7.10. Pseudorabies
• 7.11. Swine Influenza

8. Swine Vaccines Market, by Target Disease

• 8.1. Introduction
• 8.2. Arthritis
• 8.3. Bordetella Rhinitis
• 8.4. Diarrhea
• 8.5. Foot & Mouth Disease
• 8.6. Porcine Circovirus Associated Disease
• 8.7. Porcine Reproductive & Respiratory Syndrome
• 8.8. Pseudorabies
• 8.9. Swine Influenza

9. Americas Swine Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Swine Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Swine Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing